scanance.
Sign inGet Premium
CH

Chemed Corporation

CHEHealthcareNASDAQ

Medical Care Facilities · Last scanned May 29, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot
MA150+3.54%
$424.87

Price above medium-term moving average.

MA200+2.20%
$430.40

Above long-term trend line.

RSI-14neutral
69.0

Balanced. Not overbought, not oversold.

MACDnegative
-0.1439

Histogram negative — downward momentum.

Financials · Annual
Revenue
$2.53B
+4.1% YoY
Net Income
$265.2M
-12.2% YoY
EBITDA
$422.4M
-9.0% YoY
Free Cash Flow
$348.3M

Scan Results

Daily timeframe

1 of 4 indicators bearish as of May 28

DateIndicatorDetails
Loading...
About Chemed Corporation

Part of the healthcare sector, Chemed Corporation (CHE) is listed under Medical Care Facilities. With a market capitalization of $5.84B, it sits in mid-cap territory. The company operates through two segments: VITAS and Roto-Rooter segments.

Key stats
Market Cap$5.84B
P/E (TTM)24.04
Fwd P/E16.35
EPS$18.30
Beta0.54
52W Change-23.5%
Dividend Yield0.55%
ROE25.6%
Analysis

Chemed Corporation carries $236.9M in total debt against $16.9M in cash reserves — debt is roughly 14.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $348.3M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 25.6% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 12.8% further supports the picture of efficient asset utilization. Revenue has been uneven over recent years, ranging from $2.14B to $2.53B.

CHE's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Chemed Corporation and its sector.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms